Traditional Admission Path

All applicants to the M.D. program who consider NEOMED their medical school of choice and are strongly aligned with its mission are encouraged to apply electing the Early Decision Plan (EDP).

• Early Decision is binding, which means that candidates who receive offers of admission are obligated by AMCAS policy to attend NEOMED should they wish to attend any allopathic school of medicine.
• All Early Decision applicants must present valid MCAT scores, apply through AMCAS by August 1, and have the secondary application (by invitation only) complete and verified to the Office of Admissions by August 28 of the year before anticipated enrollment.
• Notification to the applicant regarding admission is given by October 1. If selected, an EDP admit receives the benefit of early notification of acceptance and is, therefore, obligated to attend the NEOMED College of Medicine under American Association of Medical Colleges (AAMC) admission policy. If not selected for admission through the early decision plan, applicants may then apply to other medical schools. For more about consideration of whether the early decision program is right for you, visit students-residents.aamc.org.

Applicants to the M.D. program who wish to apply to NEOMED and other medical schools in a competitive admission process are encouraged to apply electing the Regular Decision Plan (RDP).

• Regular Decision is non-binding, which means that candidates who receive offers of admission may choose from all medical school acceptances in line with AMCAS policy and medical school “Choose Your Medical School Tool” policies and deadlines.
• All Regular Decision applicants must present valid MCAT scores, apply through AMCAS by November 1, and have the secondary application (by invitation only) complete and verified to the Office of Admissions by Dec. 1 of the year before anticipated enrollment.
• Notification to the applicant regarding admission is given on a rolling basis. Generally, the first round of RDP acceptances are communicated in late January. RDP students may be accepted on a rolling admission basis through July.   For more about consideration of whether regular decision is right for you, visit students-residents.aamc.org.

Graduate Studies Special Program Plan

At the end of the admission cycle, some Regular Decision applicants on the alternate list may be invited to reserve a seat in the following year’s M.D. class through the Graduate Studies Special Program Plan.

This option is available by invitation only. Eligible applicants from the prior year’s M.D. applicant pool may complete a NEOMED master’s degree during a gap year and apply again through AMCAS using the “Other Special Program” admission plan.

NEOMED matriculated about 45 students through this pathway in each of the past two admission cycles. In 2025 and 2026, all eligible students who were interested in participating were offered a place in the program, accounting for about 40% of the entering M.D. class.

Applicants interested in NEOMED’s combined M.D./Ph.D. program should apply through AMCAS and select the M.D./Ph.D. application plan. Learn more on the AMCAS website: About applying to M.D.-Ph.D. programs.

With one application, candidates apply to both of these NEOMED programs:

1. Doctor of Medicine (M.D.) program
2. Doctor of Philosophy (Ph.D.) in Basic and Translational Biomedicine

Faculty from both programs review M.D./Ph.D. applicants. Candidates may be invited to interview for both programs, and admission to the combined program requires approval from both the M.D. and Ph.D. admission committees.

For questions about the Ph.D. in Basic and Translational Biomedicine, contact Matthew Smith, Ph.D., co-director of the Basic & Translational Biomedicine Graduate Program and assistant professor in the College of Graduate Studies.